MIRA INFORM REPORT

 

 

Report Date :

29.05.2013

 

IDENTIFICATION DETAILS

 

Name :

RUELENS RAYMOND

 

 

Registered Office :

Lange Ridderstraat 13, 2800 Mechelen

 

 

Country :

Belgium

 

 

Date of Incorporation :

17.04.1991

 

 

Com. Reg. No.:

515820165

 

 

Legal Form :

Proprietorship Concern

 

 

Line of Business :

Wholesaler of pharmaceutical goods

 

 

No. of Employees :

1 to 4 employees

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Small Concern  

 

 

Payment Behaviour :

No  Complaints

 

 

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Belgium

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BELGIUM - ECONOMIC OVERVIEW

 

This modern, open, and private-enterprise-based economy has capitalized on its central geographic location, highly developed transport network, and diversified industrial and commercial base. Industry is concentrated mainly in the more heavily-populated region of Flanders in the north. With few natural resources, Belgium imports substantial quantities of raw materials and exports a large volume of manufactures, making its economy vulnerable to volatility in world markets. Roughly three-quarters of Belgium's trade is with other EU countries, and Belgium has benefited most from its proximity to Germany. In 2011 Belgian GDP grew by 1.8%, the unemployment rate decreased slightly to 7.2% from 8.3% the previous year, and the government reduced the budget deficit from a peak of 6% of GDP in 2009 to 4.2% in 2011 and 3.3% in 2012. Fourth quarter GDP growth in 2012 was at -0.1%, the third consecutive quarter of negative growth. This brought economic growth for the whole of 2012 to negative 0.2%. It also left Belgium on the brink of a possible recession at the end of 2012. However, at year's end, the government appeared close to meeting its 2012 budget deficit goal of 3% of GDP. Despite the relative improvement in Belgium's budget deficit, public debt hovers around 100% of GDP, a factor that has contributed to investor perceptions that the country is increasingly vulnerable to spillover from the euro-zone crisis. Belgian banks were severely affected by the international financial crisis in 2008 with three major banks receiving capital injections from the government, and the nationalization of the Belgian retail arm of a Franco-Belgian bank.

 

Source : CIA

 


REGISTERED NAME & CONCERN  SUMMARY

 

Business number

515820165

Registered name

RUELENS RAYMOND 

Address

LANGE RIDDERSTRAAT 13

 

2800 MECHELEN

Date of establishment

17/04/1991

Telephone number

015211294

Fax number

-

 

DIRECTORS/MANAGEMENT

 

Current director details

Name

RAYMOND RUELENS

Position

Proprietor

Start Date

28/07/1996

Date of birth

16/07/1949

 

NEGATIVE INFORMATION

 

Court data summary

Bankruptcy details

Court action type

no

Protested bills

Bill amount

-

NSSO details

Date of summons

-

 

Business number

515820165

Registered name

RUELENS RAYMOND

Fax number

-

Date founded

17/04/1991

Concern  status

active

Concern  type

Proprietorship

Currency

Euro (€)

Date of latest accounts

-

Activity code

46460

liable for VAT

yes

Activity description

Wholesale of pharmaceutical goods

VAT Number

BE.0515.820.165

Belgian Bullettin of Acts Publications

moniteur belge

 

 

 

Protested bills

Drawee name

-

Address

-

Bill amount

-

Bill currency

-

Maturity of bill

-

Name of drawer

-

City of drawer

-

 

NSSO details

Business number

515820165

Name of defendant

-

Legal form of defendant

-

Date of summons

-

Labour court

-

 

Bankruptcy details

There is no bankruptcy data against this concern .

 

 

Court data

There is no data for this concern .

 

 

SHARE & SHARE CAPITAL INFORMATION

 

Minority Shareholders

No minority shareholders found.

 

Minority Interests

No minority interests found.

 

PAYMENT INFORMATION

 

Payment expectations

Past payments

 

Payment expectation days

-

Industry average payment expectation days

63.99

Industry average day sales outstanding

150.79

 

Suspension of payments / moratorium history

Amount

-

Details

-

 

Payment expectations

Payment expectation days

-

Day sales outstanding

-

 

Industry comparison

Activity code

46460

Activity description

Wholesale of pharmaceutical goods

Industry average payment expectation days

63.99

Industry average day sales outstanding

150.79

 

Industry quartile analysis

Payment expectations

Concern  result

-

Lower

107.41

Median

71.81

Upper

39.88

 

Day sales outstanding

Concern  result

-

Lower

82.93

Median

47.30

Upper

23.78

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Group Structure

No group structure for this concern .

 

FINANCIAL INFORMATION

 

There are no accounts on file for this concern 

 

FOREIGN EXCHANGE RATES

 

Accounts

No key Financials Registered.

 

Trends

Profitability

-

Liquidity

-

Net worth

-

 


ADDITIONAL INFORMATION

 

Contractor details

Registered contractor number

-

Contractor description

-

Date struck off register

 

 

Personnel (NSSO classification)

Code

-

Description

FROM 1 TO 4 EMPLOYEES

 

Joint Industrial Committee (JIC)

 

Limit History

no limit history data found.

 

Industry comparison

Activity code

46460

Activity description

Wholesale of pharmaceutical goods

 

NOTES & COMMENTS

 

Commentary

The business was established over 22 years ago.

Neutral

The business has 1 employees.

Neutral

The business has been at the address for over 17 years.

Neutral

The credit rating for this business has increased from 75 to 78.

Positive

The credit limit for this business has decreased from €3000 to €1500.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.99

UK Pound

1

Rs.84.19

Euro

1

Rs.71.86

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.